Spinal Cord Injury Investor Symposium: Inteligex's CEO on stem cells that are designed to account for regional identity differences within the spinal cord, and also engineering a proliferation factor

blonca9
Jun 27, 2024
1 min read

Paul Bradshaw explains how Inteligex's "ReStaRT Cells" are designed with a regional identity, and the rationale for engineering them to express the ChABC and GDNF genes to boost the odds of survival and proliferation.

Recent Posts

See All

ASCO 2025: France based Transgene presented data for its personalized cancer vaccine in the adjuvant setting for HPV- head and neck cancer

ASCO 2025: Candel Therapeutics CEO Paul Peter Tak describes phase 3 prostate cancer data from the company's off-the-shelf, adeno delivered, cancer immunotherapy

ASCO 2025: Strand Therapeutics Co-Founder & CEO Jake Becraft discusses the clinical data presentation for the company's IL-12, self-replicating mRNA cancer immunotherapy

Spinal Cord Injury Investor Symposium: Inteligex's CEO on stem cells that are designed to account for regional identity differences within the spinal cord, and also engineering a proliferation factor

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight